Enhanced Testing Service Capabilities | Newly Configured Ion Chromatograph
Classification: Company News
Publication:2022-10-26 12:47
Good news! Good news! In the golden autumn of October, the “Biopharmaceutical R&D Public Service Platform” at the Shanghai International Medical Park has once again welcomed a new addition—the Shimadzu IC‑16 ion chromatograph.

(Shimadzu IC-16 Ion Chromatograph)
The platform was established in 2011 as a public R&D service platform in the biopharmaceutical field, jointly founded by Shanghai International Medical Park Venture Capital Development Co., Ltd. and SyncoZymes (Shanghai) Co., Ltd. It is managed and operated by SyncoZymes, with a dedicated facility spanning 660 square meters. Its mission is to provide biopharmaceutical companies both within and outside the park with technical and testing services for R&D, thereby reducing R&D innovation costs, accelerating the development process, and fostering the growth of enterprises and the industry.
Since 2017, the platform has been among the first batch of service providers to join the Pudong New Area Science and Technology Innovation Voucher Information Service Platform, and over the past five years it has repeatedly earned the “Outstanding Service Provider” designation. With a dedicated team, professional services, and a customer‑centric approach to co‑creating the future, the platform offers expert quality research and testing services, serving more than 300 enterprises annually and processing over 50,000 samples each year.
The platform is equipped with more than twenty large-scale scientific instruments: the chemist’s “keen eye”—a nuclear magnetic resonance spectrometer; the “quick molecular‑weight estimator”—an LC–MS/GC–MS system; various models of “purification powerhouses”—preparative chromatographs; the “residual solvent detective”—a gas chromatograph; and a range of high‑performance liquid chromatographs. In addition, it features smaller specialized instruments such as potentiometric titrators, moisture analyzers, and muffle furnaces. For biopharmaceutical R&D, it offers large‑scale equipment like protein purifiers and electroporators. Furthermore, the platform has established a shared laboratory in collaboration with the State Key Laboratory of Crystal Engineering at East China University of Science and Technology, providing customers with a full suite of polymorph‑identification services, including XRPD (X‑ray powder diffraction), DSC (differential scanning calorimetry), TGA (thermogravimetric analysis), and SXRD (X‑ray single‑crystal diffraction).
In early 2022, to enhance the service capabilities of its R&D public‑service platform, the platform acquired a new addition to its analytical instrumentation: a CORONA‑type CAD detector, offering an improved option for the mass analysis of non‑volatile or semi‑volatile organic compounds that are either UV‑free or exhibit weak UV absorption. This month, the platform has once again expanded its cutting‑edge equipment portfolio with the introduction of a Shimadzu IC‑16 ion chromatograph, laying a robust hardware foundation for customers’ ion‑compound analysis needs.
The platform’s existing liquid chromatography, gas chromatography, mass spectrometry, and nuclear magnetic resonance instruments can meet the analytical requirements of most organic compounds; however, analyzing ionic compounds often proves challenging. Ion chromatography employs an ion-exchange resin as the stationary phase packed into a chromatographic column, with an eluent serving as the mobile phase. As the sample is carried through the column by the eluent, the different analytes—due to their varying affinities for the ion-exchange resin—travel at different rates, eventually eluting sequentially from the other end of the column, thereby achieving separation. When both a separation column and a suppressor column are used, this approach is known as dual‑column ion chromatography, or chemically suppressed ion chromatography. In contrast, when no suppressor column is employed, it is referred to as single‑column ion chromatography, or non‑suppressed ion chromatography. Chemically suppressed ion chromatography can be further classified into high‑performance ion chromatography (HPIC), hydrophilic interaction ion exchange chromatography (HPIEC), and mobile-phase ion chromatography (MPIC). HPIEC relies on the principle of ion exclusion and is suited for the separation and quantification of organic acids and amino acids; MPIC exploits adsorption and the formation of ion pairs, primarily used for separating hydrophobic cations and anions as well as metal complexes. The ion chromatograph recently acquired by this platform is of the HPIC type, whose primary separation mechanism is ion exchange, making it suitable for the analysis of inorganic cations and anions such as fluoride, chloride, carbonate, sulfate, sodium, ammonium, potassium, magnesium, calcium, iron, and zinc.
The service items currently available on the platform are listed in the table below:

If you have any of the above service requirements, please contact Manager He at 021-68187180-806 or via email at jwhe@syncozymes.com.
Leave a Message Online
Shanghai Public Security Bureau Internet Information Service Security Filing No. 31011502015262